Categories

Looking back, my journey with cancer really began when I was 40, a year after my paternal grandmother passed away. That was about the same time I first started thinking that breast cancer might be hereditary. My grandmother had a history of breast cancer, so I looked at my husband and said, “Oh my gosh,…

Continue Reading

I never had a chance to meet my paternal grandfather, Eric. He was a handsome truck driver just like my Dad. In 1950, Eric had surgery to remove colon cancer at age 39. The operation went well and he was able to return to work. But the cancer returned eight years later and he lost…

Continue Reading

There are moments in every life that have staying power. You’ll always know where you were when “it” happened. Sometimes these are collective shared memories, such as where you were on 9/11 or, for my parents’ generation, where they were when JFK was shot. At other times, the moment in question is more personal: where…

Continue Reading

I think it is so important for me to tell my story — mostly because it is probably similar to other women’s stories, but also because it helps keep me focused on awareness and being an advocate for genetic testing. As Ovarian Cancer Awareness Day on May 8 approaches, I realize it was just 4…

Continue Reading

As I looked at the pathology report bearing my name and the words “poorly differentiated ductal carcinoma of the left breast,” feelings of overwhelming dread set in, along with nausea. “Well Michelle, as always, you do it up big,” said my healthcare professional. “Your cancer is the worst, most aggressive kind.” He explained that poorly…

Continue Reading

October is Breast Cancer Awareness Month and once again Myriad Genetics, Inc. is proud to be joining efforts with the American Cancer Society to support Making Strides against Breast Cancer. Mark your calendar and join us at this year’s Making Strides Against Breast Cancer Walk scheduled for Saturday October 12, 2013 from 8:00am to 1:00pm…

Continue Reading

Break Out the Teal! September is Ovarian Cancer Awareness Month! According to the National Cancer Institute’s website 22,240 women will be diagnosed with ovarian cancer in 2013. Approximately 11 – 15% of these diagnosed ovarian cancer cases are caused by mutations in the BRCA1 or BRCA2 genes. That means that 1 in 7 women who…

Continue Reading

Today, May 8th 2013 marks the very first World Ovarian Cancer Day. Today several organizations from around the world will join forces to raise awareness about ovarian cancer and to help educate the public about its symptoms. Approximately 11-15% of ovarian cancer cases are caused by mutations in the BRCA1 or BRCA2 genes. When someone…

Continue Reading

The Preventive Care marketing team had the opportunity to attend the ACOG District II show in New York a few weeks ago. This year Myriad had a presentation about Incorporating Hereditary Cancer Risk Assessment into healthcare professionals’ practices.  Dr. Frieder from California attended and spoke along with one of our patients, Cynthia Kimball.  Cynthia was…

Continue Reading

The National Ovarian Cancer Coalition (NOCC)’s 2012 Conference in Las Vegas, Nevada was held November 8th through 10th. Survivors, caregivers, healthcare professionals, and family members gathered to embrace the great strides and impact being made by the NOCC in their mission to raise awareness about the signs and symptoms of ovarian cancer. Myriad provided a…

Continue Reading

This fall Myriad participated in eleven National Ovarian Cancer Coalition Walks to Break the Silence on Ovarian Cancer with just one more walk to go in San Antonio, Texas this November.  Between team building, fundraising, information giving, walking and just plain having fun, Myriad was able to raise awareness about both hereditary breast and ovarian…

Continue Reading

Leslie had everything planned for her upcoming Thanksgiving feast. Her Christmas shopping lists were in order, and she was ready to host the rehearsal party for her son’s December 28th wedding. What she wasn’t ready for, was the unexpected arrival of cancer. In the 1970s I lost both of my parents to cancer. They were…

Continue Reading

Today was an inspirational day here at Myriad.  We had two amazing speakers on hand to discuss their organizations, David Barley, CEO of National Ovarian Cancer Coalition, (NOCC) as well as a representative from Bright Pink.  It was very powerful to hear about all the amazing advocacy work each organization is doing.  (Pictured Above: David Barley,…

Continue Reading

September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor refers to an individual who carries a strong predisposition to cancer but has not developed cancer. These individuals proactively sought out knowledge to determine if they inherited a gene mutation by having genetic testing…

Continue Reading

In 2010, Congress passed a resolution declaring the last week of September as National Hereditary Breast and Ovarian Cancer (HBOC) Week (September 23–30, 2012) and the last Wednesday of the month as National Previvor Day (September 26, 2012). THE BRAC CHALLENGE During HBOC Week, Myriad will donate to Bright Pink, NOCC (National Ovarian Cancer Coalition),…

Continue Reading

More than 20,000 women are diagnosed with ovarian cancer each year, and approximately 15,000 women die from the disease each year. Since there is no early detection test, most cases are diagnosed in later stages when prognosis is poor. When ovarian cancer is found early at a localized stage, prognosis is good for the majority…

Continue Reading